Compare Medtronic PLC (MDT) vs Taskus Inc (TASK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Taskus Inc — how do they compare? Medtronic PLC trades at $88.48 (market cap $112.24B), while Taskus Inc trades at $8.14 (market cap $723.41M). The key difference: Medtronic PLC is far larger — about 155.2× Taskus Inc's market cap, and Medtronic PLC pays a 3.28% dividend while Taskus Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Taskus Inc for 34 Days on average.
| MDT | TASK | |
|---|---|---|
Market Cap | $112.24B | $723.41M |
Volume | 105,663,236 | 201,303 |
Sector | Health | Technology |
52-Week High | $105.35 | $14.30 |
52-Week Low | $73.75 | $4.57 |
Typical Hold Time | 63 Days | 34 Days |
Enterprise Value | $131.58B | $1.09B |
Dividend Yield | 3.28% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $87.75, up 2.62% today, with strong analyst support (60.8% buy ratings) and a $97.80 consensus price target suggesting 11.5% upside. The stock shows consistent earnings beats in recent quarters and maintains a 49-year dividend growth streak. However, technical indicators signal bearish momentum with resistance near $89-90. Revenue growth accelerated to $33.54B in 2025 with net margins improving to 13.93%, though debt levels have risen to 31.1% of assets.
MDT presents a compelling value opportunity with attractive dividend yield and earnings momentum, but faces near-term technical headwinds and increasing leverage. The upcoming Q3 earnings report and MiniMed separation will be critical catalysts. Investors should weigh the strong fundamental recovery against bearish technical signals and monitor debt management closely.
TaskUs (TASK) trades at $8.01, up 1.52% today, with a bearish technical signal but strong fundamentals. The company reported Q2 2026 revenue of $308.9 million, beating estimates, with net income margin improving to 8.75% in 2025. Valuation ratios appear attractive, with a P/E of 6.8 and P/S of 0.6, while analyst consensus is a Buy with a $9.33 price target. Recent news highlights AI services growth offsetting declines in other segments.
The outlook is mixed; low valuations and AI-driven revenue growth present upside, but technical bearishness and margin pressures from labor costs pose risks. Investors should weigh fundamental strength against near-term price volatility and competitive challenges in the digital services space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Taskus Inc
TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to innovative and disruptive technology companies. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
Read more on TASK →
